<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Therapeutic effects of a minor tranquilizer (from the group of <z:chebi fb="13" ids="22720">benzodiazepines</z:chebi>) tranxene were studied in patients presenting with psychoemotional disorders in the presence of the <z:hpo ids='HP_0003674'>onset</z:hpo> moderately severe atherosclerotic dyscirculatory <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The patients derived apparent benefit from the treatment administered as per subjective as well as objective evidence: the levels of <z:e sem="disease" ids="C0020604" disease_type="Mental or Behavioral Dysfunction" abbrv="">hypochondria</z:e>, <z:hpo ids='HP_0000716'>depression</z:hpo>, hysterioidness, psychoasthenicity, got significantly decreased, with positive changes being recordable in EEG as well as REG </plain></SENT>
<SENT sid="2" pm="."><plain>The results obtained allow tranxene to be recommended for use in geriatric practice in patients presenting with cerebral <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> accompanied by psychoemotional disorders </plain></SENT>
</text></document>